Table 2.
Formulation Code⁎ |
Amount Released (%) |
Release Model |
|||||
---|---|---|---|---|---|---|---|
Q24h | Q4w | Zero |
Diffusion |
Korsmeyer-Peppas |
|||
r2 | r2 | r2 | k | n | |||
RSNP1 | 30.130.40 | 95.311.67 | 0.8590.007 | 0.9710.001 | 0.9840.006 | 7.2980.027 | 0.4040.002 |
RSNP2 | 27.292.36 | 98.720.52 | 0.8910.002 | 0.9840.002 | 0.9870.005 | 6.7300.108 | 0.4170.004 |
RSNP3 | 32.002.44 | 90.521.22 | 0.8690.011 | 0.9740.007 | 0.9890.003 | 10.0002.353 | 0.3430.043 |
RSNP4 | 32.671.75 | 96.610.36 | 0.8770.008 | 0.9710.005 | 0.9720.018 | 9.3690.458 | 0.3580.010 |
RSNP5 | 28.590.58 | 86.289.47 | 0.8660.007 | 0.9760.004 | 0.9760.003 | 10.1701.224 | 0.3340.005 |
RSNP6 | 31.180.16 | 89.921.58 | 0.8260.018 | 0.9560.007 | 0.9780.001 | 9.8270.070 | 0.3510.005 |
AL-RSNP | 22.562.11 | 81.524.81 | 0.8420.013 | 0.9680.005 | 0.9860.004 | 6.3990.106 | 0.4080.006 |
Abbreviations: RSNP, Rosuvastatin-entrapped silica nanoparticles; AL-RSNP, Alginate-loaded rosuvastatin-entrapped silica nanoparticles; Q24h, % drug released after 24 h; Q4w, % drug released after 4 weeks.
The composition of the prepared RSNP is found in Table 1. AL-RSNP is composed of Alginate matrix loaded with the selected Rosuvastatin-entrapped silica nanoparticle (RSNP2).